NCT05285605View on ClinicalTrials.gov

Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

January 22, 2024

Conditions
ContraceptionContraceptive UsageReproductive Issues
Interventions
DRUG

Ulipristal Acetate

Ulipristal acetate 30mg x 1 dose as needed for unprotected intercourse

Trial Locations (1)

60611

Northwestern Medicine Prentice Women's Hospital, Chicago

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

Northwestern University

OTHER